Carcinoembryonic antigen is a diagnostic marker for many cancers including colorectal, hepatoma, neuroendocrine, lung, neuroblastoma, breast, pancreatic, trophoblastic and ovarian cancers.
| Inventor | Institute |
|---|---|
| Lindy Durrant | University of Nottingham |
| Cat. #: | 151306 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell biology |
| Application: | ELISA ; IP ; WB |
| Target: | Carcinoembryonic Antigen (CEA) |
| Reactivity: | Human |
| Clone: | 161 (NCRC16) |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | Carcinoembryonic antigen is a diagnostic marker for many cancers including colorectal, hepatoma, neuroendocrine, lung, neuroblastoma, breast, pancreatic, trophoblastic and ovarian cancers. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Immunogen: | Colon cancer cell lines |
| Myeloma used: | P3/NS1/1-Ag4.1 |
| Target background: | Carcinoembryonic antigen is a diagnostic marker for many cancers including colorectal, hepatoma, neuroendocrine, lung, neuroblastoma, breast, pancreatic, trophoblastic and ovarian cancers. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Durrant et al. 1989. Br J Cancer. 60(6):855-60. PMID: 2481485. Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151026 | Anti-FCGR1 [10.1] mAb |
Key Info
Anti-FCGR1 [10.1] mAb
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.